Test maker and health tech company Cue Health Inc. is seeking to sell more than 12 million shares in a range between $12 and $17 each, looking to raise more than $244 million, according to an amended filing on Wednesday. The San Diego, Calif.-based company filed for an initial public offering earlier this month. Cue Health said its revenue rose to $23 million last year from $6.6 million in 2019. The company listed earnings of 22 cents a share in the six months ended in June, compared with a loss of $1.21 a share in the year-ago period. Underwriters for the IPO include Goldman Sachs and Morgan Stanley, and Cue is expected to trade on the Nasdaq under the symbol HLTH.
